The role of the gut microbiome (GM) and oral microbiome (OM) in cardiovascular disease (CVD) has been increasingly being understood in recent years. It is well known that GM is a risk factor for various CVD phenotypes, including hypertension, dyslipidemia, heart failure and atrial fibrillation. However, its role in valvular heart disease (VHD) is less well understood. Research shows that, direct, microbe-mediated and indirect, metabolite-mediated damage as a result of gut dysbiosis and environmental factors results in a subclinical, chronic, systemic inflammatory state, which promotes inflammatory cell infiltration in heart valves and subsequently, via pro-inflammatory molecules, initiates a cascade of reaction, resulting in valve calcification, fibrosis and dysfunction. This relationship between GM and VHD adds a pathophysiological link to the pathogenesis of VHD, which can be aimed therapeutically, in order to prevent or regress any risk for valvular pathologies. Therapeutic interventions include dietary modifications and lifestyle interventions, in order to influence environmental factors that can promote gut dysbiosis. Furthermore, the combination of probiotics and prebiotics, as well as fecal m transplantation and targeted treatment with inducers or inhibitors of microbial enzymes have showed promising results in animal and/or clinical studies, with the potential to reduce the inflammatory state and restore the normal gut flora in patients. This review, thus, is going to discuss the pathophysiological links behind the relationship of GM, CVD and VHD, as well as explore the recent data regarding the effect of GM-altering treatment in CVD, cardiac function and systemic inflammation.

Oral anticoagulation (OAC) is essential for preventing ischemic stroke events in patients with atrial fibrillation (AF), and leads to a significant ischemic prophylaxis, when appropriately used. However, there is still a risk of experiencing stroke events, despite being under anticoagulation. Stroke despite OAC is an increasingly common diagnosis, and pathophysiologically, it can be associated with several etiologies, ranging from AF competing mechanisms to true anticoagulation failure. While the cardioembolic origin of stroke is the most frequently identified etiology, other factors also have to be considered, as there is a significance risk of coexistence. This highlights the need for thorough diagnostic testing, evaluating each stroke etiology independently, with the use of imaging, biomarker and blood tests. Treating such patients, however, is more complex, as there is still uncertainty regarding the selection of OAC post-stroke, with data showing a superiority of direct OAC (DOAC), compared to vitamin K antagonists, in recurrent ischemic stroke prevention and conflicting results regarding OAC switch. Finally, the additive value of cardiac interventions, such as left atrial appendage occlusion (LAAO), in secondary prevention of stroke, is being explored, as it could potentially lead to significant stroke risk reduction. This review, therefore, provides an updated summary of the pathophysiology, diagnostics and therapeutics of stroke under OAC, while also discussing the future direction on the Achilles heel of AF management.

Making patients safer and improving the quality of the treatment received in hospitals depends on improvements in the way healthcare is run. These fresh concepts improve clinical outcomes and patient care by means of sophisticated technology, process optimisation, and data-driven tactics, thereby strengthening healthcare systems. This is so that healthcare systems, handling more patients and more complex clinical scenarios, may be Among the most significant developments are using artificial intelligence (AI) and machine learning (ML) in decision-making. Accurate diagnosis, tailored treatment strategies, and proactive patient monitoring are therefore made feasible. By use of predictive analytics and artificial intelligence systems, one may identify potential hazards, therefore reducing errors and ensuring appropriate timing of action. Particularly in rural and underdeveloped regions, telemedicine has also altered a lot regarding the management of healthcare. By allowing physicians to interact with patients from far-off, telemedicine increases access to healthcare services and monitors patients. Electronic health records (EHR) have also streamlined handling patient information. this is in order that clinicians may additionally make higher decisions as they offer reliable, real-time access to clinical know-how, take a look at findings, and therapy guidelines. Another extensive development is the use of robotic systems in affected person care and healing procedures. These techniques significantly boom sufferers' healing periods via making treatments pretty specific, consequently lowering mistakes. While still making sure sufferers get the great treatment feasible, using robots for therapy and affected person tracking allows healthcare specialists to simplify their tasks. The usage of internet of things (IoT) devices, actual-time tracking systems additionally reveal patients' health constantly and notify healthcare body of workers at once need to something occur that might be elaborate. This reduces the dangers associated with responding too slowly and quickens remedy. These traits also are facilitating the cooperation of people from all backgrounds, which improves coordination of patient care, communication among healthcare specialists, and an extra all-encompassing method to affected person protection.